Judging from the numbers I'm seeing, the black market for weight-loss jabs isn't small-scale. This is a massive operation.

Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...

Novo Nordisk faces headwinds from regulatory uncertainty, competitive efficacy gaps with Eli Lilly and technical downward ...

A new Gallup poll indicates that the obesity rate among U.S. adults has declined over the past three years as the number of ...

A groundbreaking study has compared the three top weight loss medications on the market, which has produced some surprising ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Wegovy can help people with excess weight and obesity lose ...

LONDON (Reuters) -Novo Nordisk's late bid to hijack Pfizer's takeover of U.S. obesity biotech Metsera marks an aggressive ...

The New York-based biotech is at the centre of a bidding war between Novo Nordisk and Pfizer, both vying for access to its ...

Metsera, Inc. is at the center of a bidding war between Novo Nordisk and Pfizer, driving its stock up 20%. Learn more about ...

The Wegovy and Ozempic maker’s offer comes after Pfizer last month agreed to a lower deal to acquire the Nasdaq-listed ...

Americans are getting slimmer; Gallup says the obesity rate has decreased along with increased use of weight loss drugs such ...

Shares of the world's largest healthcare company by market value were up nearly 2% in morning trading even as investors remain wary of drug price negotiations with the Trump administration.